We are live on ! Find out more
ABMD

Abiomed Inc
ABMD

Delisted

ABMD was delisted on the 21st of December, 2022.

Back to rankings

460 hedge funds and large institutions have $10.5B invested in Abiomed Inc in 2020 Q2 according to their latest regulatory filings, with 90 funds opening new positions, 140 increasing their positions, 166 reducing their positions, and 40 closing their positions.

New
Increased
Maintained
Reduced
Closed

125% more first-time investments, than exits

New positions opened: 90 | Existing positions closed: 40

68% more capital invested

Capital invested by funds: $6.25B → $10.5B (+$4.23B)

67% more funds holding in top 10

Funds holding in top 10: 3 → 5 (+2)

12% more funds holding

Funds holding: 412 → 460 (+48)

13% less call options, than puts

Call options by funds: $154M | Put options by funds: $177M

16% less repeat investments, than reductions

Existing positions increased: 140 | Existing positions reduced: 166

Holders
460
Holders Change
+48
Holders Change %
+11.65%
% of All Funds
9.43%
Holding in Top 10
5
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+66.67%
% of All Funds
0.1%
New
90
Increased
140
Reduced
166
Closed
40
Calls
$154M
Puts
$177M
Net Calls
-$22.9M
Net Calls Change
+$54M

Top Buyers

Rank Fund Capital Flow
1
JP Morgan Chase
JP Morgan Chase
New York
+$49.8M
2
Wells Fargo
Wells Fargo
California
+$48M
3
JSP
Jackson Square Partners
California
+$44.5M
4
William Blair Investment Management
William Blair Investment Management
Illinois
+$41.2M
5
Renaissance Technologies
Renaissance Technologies
New York
+$40.6M

Top Sellers

Rank Fund Capital Flow
1
Wellington Management Group
Wellington Management Group
Massachusetts
-$115M
2
AllianceBernstein
AllianceBernstein
Tennessee
-$79.2M
3
Primecap Management
Primecap Management
California
-$56.5M
4
DM
Deerfield Management
New York
-$54.6M
5
GPP
Great Point Partners
Connecticut
-$31.4M
Name Holding Trade Value Shares
Change 		Change in
Stake
GCM
251
Gunderson Capital Management
South Carolina
$863K +$718K +3,574 New
VIA
252
Vident Investment Advisory
Georgia
$831K +$367K +1,829 +113%
PP
253
Prudential plc
United Kingdom
$831K +$691K +3,441 New
BCM
254
Brookstone Capital Management
Illinois
$826K +$156K +779 +29%
US Bancorp
255
US Bancorp
Minnesota
$815K +$133K +664 +25%
II
256
IFM Investors
Australia
$795K -$236K -1,176 -26%
Nomura Holdings
257
Nomura Holdings
Japan
$772K +$642K +3,197 New
CS
258
Candriam SCA
Luxembourg
$771K -$113K -561 -15%
ETC
259
Exchange Traded Concepts
Oklahoma
$747K +$416K +2,071 +202%
NMERB
260
New Mexico Educational Retirement Board
New Mexico
$737K +$40.2K +200 +7%
LCP
261
Legacy Capital Partners
Wisconsin
$736K +$612K +3,046 New
CGH
262
Crossmark Global Holdings
Texas
$730K -$4.02K -20 -0.7%
RIG
263
Ramiah Investment Group
Wisconsin
$728K +$7.63K +38 +1%
BF
264
BOK Financial
Oklahoma
$728K -$116K -580 -16%
AB
265
Amalgamated Bank
New York
$714K -$922K -4,591 -61%
Mirae Asset Global Investments
266
Mirae Asset Global Investments
South Korea
$712K +$46K +229 +8%
PP
267
Patten & Patten
Tennessee
$689K – – –
Rafferty Asset Management
268
Rafferty Asset Management
New York
$682K +$567K +2,822 New
Millennium Management
269
Millennium Management
New York
$680K +$113K +562 +25%
QIM
270
Quantitative Investment Management
Virginia
$680K +$566K +2,817 New
CCM
271
Coe Capital Management
Illinois
$671K -$12K -60 -2%
TI
272
Trexquant Investment
Connecticut
$668K -$995K -4,955 -64%
WBC
273
Westpac Banking Corp
Australia
$664K – – –
SMDAM
274
Sumitomo Mitsui DS Asset Management
Japan
$661K +$7.23K +36 +1%
SIM
275
Sentry Investment Management
Wisconsin
$625K +$334K +1,662 +179%
9 10
11
12 13

ABMD Hedge Fund Activity: Q2 2020 in Review

460 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in Abiomed Inc (ABMD) for Q2 2020, worth a combined $10.5B — up 68% from $6.25B a quarter earlier.

Buyers outnumbered sellers: 90 funds opened new ABMD positions and 40 closed out — a net gain of 50 holders — while 140 added to existing stakes and 166 trimmed.

The largest buyer was JP Morgan Chase, adding an estimated $49.8M. The largest seller was Wellington Management Group, cutting an estimated $115M.

  • 460 institutional investors held Abiomed Inc (ABMD) as of Q2 2020, up from 412 in Q1 2020.
  • Funds reported $10.5B of Abiomed Inc stock for Q2 2020, up 68% quarter-over-quarter.
  • 90 funds opened new Abiomed Inc positions in Q2 2020 and 40 closed out, a net change of +50 holders.
  • The largest Abiomed Inc buyer in Q2 2020 was JP Morgan Chase, an estimated $49.8M added.
  • The largest Abiomed Inc seller in Q2 2020 was Wellington Management Group, an estimated $115M sold.

Based on aggregated 13F filings for Q2 2020.